TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Peter Enzinger, MD

DFCI


Boston, Massachusetts - 02115

Dana-Farber/Harvard Cancer Center at Dana ...


Boston, Massachusetts - 02115 (617-632-4001)

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 3
  • CONDITIONS4
  • INTERVENTIONS11
  • SINCE2006
Perioperative Panitumumab and Epirubicin Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma

April 2008 - April 2011
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

September 2006 - July 2008
Cisplatin Irinotecan and Bevacizumab (PCA) Versus Docetaxel Cisplatin Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

July 2009 - July 2011
Adenocarcinoma

Esophageal Diseases

Esophageal Neoplasms

Stomach Neoplasms

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Oxaliplatin

Irinotecan

Cetuximab

Irinotecan Hydrochloride

Panitumumab, Epirubicin, Oxaliplatin, Xeloda

Epirubicin Hydrochloride

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo